Search Results
Displaying results 1 - 20 of 31
- Professor Vlado Perkovic, of The George Institute, discusses the results of the CREDENCE kidney disease trial11/4/2019 -Videoentity:node9,937,980,800,000
- 11/4/2019 -Videoentity:node9,861,208,200,000
- Standalone grabs with Professor Vlado Perkovic, of The George Institute, discusses the results of the CREDENCE kidney disease trial11/4/2019 -Videoentity:node9,823,264,400,000
- The landmark clinical trial, CREDENCE, transformed the status quo in diabetic kidney disease research by identifying the first new treatment in almost 20 years. Building on The George Institute’s…09/3/2022 -Case Studiesentity:node1,682,528,670,000
- A new treatment for people with diabetes and kidney disease reduced kidney failure rates by a third, according to a landmark study. The results, published in the New England Journal of Medicine, also…14/4/2019 -Media releaseentity:node42,988,352
- Lead author Dr Brendon Neuen from The George Institute for Global Health commented: “We found SGLT2 inhibitors clearly and powerfully reduce the risk of kidney failure.” “These findings…02/9/2019 -Media releaseentity:node41,375,360
- The CREDENCE trial, investigating a breakthrough treatment for chronic kidney disease and type 2 diabetes, has been ended early after benefit was demonstrated at an interim analysis. The study, being…17/7/2018 -Media releaseentity:node40,586,072
- For two decades, The George Institute has been at the forefront of global efforts to improve kidney disease treatment around the world, as Professor Vlado Perkovic explains. Vlado…12/11/2019 -Profile storyentity:node150,209.48
- The number of people living with diabetes is increasing worldwide at an alarming rate. According to the International Diabetes Federation (IDF), diabetes is one of the fastest growing health…13/11/2020 -Newsentity:node31,060.805
- Worldwide, 160 million people with type 2 diabetes have or are at risk of developing chronic kidney disease. We identified the first new treatment for diabetic kidney disease in 20 years. The…25/2/2020 -Landing Pageentity:node26,434.191
- The George Institute’s Dr Zien Zhou has been awarded almost $1,000,000 over three years to evaluate the use of brain magnetic resonance imaging (MRI) to identify ‘hidden’ changes to blood vessels in…08/3/2023 -Newsentity:node25,999.727
- 2019 has certainly been significant for The George Institute for Global Health - not only did we celebrate our 20th year but we also delivered ground-breaking research that will have a positive…20/12/2019 -Newsentity:node25,708.326
- Take a look at our five most-read research stories in 2018: 1. Innovative triple pill significantly lowers blood pressure A new low dose three in one pill to treat hypertension could transform…17/12/2018 -Newsentity:node25,479.865
- 1.7 million Australians have diabetes and around two-thirds also have cardiovascular disease, chronic kidney disease or both. Each year in Australia hospital admissions for cardiovascular disease and…17/3/2021 -Newsentity:node25,255.43
- A/Professor Meg Jardine is a Honorary Professorial Fellow at The George Institute for Global Health. Her research interests centre on preventing the progression and complications of…entity:user0
- Dr Tamara Young is a UPA supported PhD scholar at the George Institute. She is a dual trained Endocrinologist and General and Acute Care Medicine Physician, and has a strong interest in Nephrology,…entity:user0
- Publicationentity:bibcite_reference0
- Publicationentity:bibcite_reference0
- Publicationentity:bibcite_reference0
- Publicationentity:bibcite_reference0